Literature DB >> 25274108

Association of smoking and alcohol drinking with dementia risk among elderly men in China.

Shiming Zhou, Rui Zhou, Tingting Zhong, Rui Li, Jun Tan, Huadong Zhou1.   

Abstract

BACKGROUND: Previous studies relating smoking and alcohol drinking with the incidence of dementia have been inconsistent.
OBJECTIVES: We assessed whether smoking and alcohol drinking was associated with the risk of dementia, including Alzheimer disease (AD) and vascular dementia (VaD) after seven years of follow-up.
DESIGN: We prospectively analysed the incidence of dementia from 2004 to 2011 among 2959 elderly men, according to their smoking and alcohol drinking status.
SETTING: six neighbourhoods from three districts mentioned in Chongqing city. PARTICIPANTS: A total of 3170 men were followed up annually for 7 years. MEASUREMENTS: Cox proportional hazards models were established to evaluate the association between smoking, alcohol drinking and the risk of dementia.
RESULTS: The incidences of AD and VaD were higher respectively in current smoking than never smoking, daily drinking than never drinking over 7 years of follow-up (p<0.01). After adjusting for age and other potential confounders, current smoking was associated with increased risk of AD (HR= 2.14, 95% CI 1.20-4.46) and VaD (HR= 3.28, 95% CI 1.14-4.52), meanwhile, daily drinking was related to increased risk of AD (HR= 2.25, 95% CI 1.43-3.97) and VaD (HR= 3.42, 95% CI 1.18-4.51). In addition, co-smoking and drinking were related to with a significantly higher risk of AD and VaD than non-smoking and drinking (HR= 3.03, 95% CI 1.65-4.19) and VaD (HR= 3.96, 95% CI 1.64-4.71). Moreover, co-smoking and drinking had higher risk of AD and VaD compared with current smoking and daily drinking.
CONCLUSIONS: Current smoking and daily drinking were found to be significantly associated with dementia in elderly men.

Entities:  

Mesh:

Year:  2014        PMID: 25274108      PMCID: PMC4428477          DOI: 10.2174/1567205011666141001123356

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


INTRODUCTION

Addiction to smoking and alcohol drinking are serious problems of public health in worldwide, especially in China [1, 2]. Smoking and alcohol drinking are closely related to atherosclerosis, cardiovascular disease, stroke, hypertension, diabetes mellitus, dementia, etc. [3, 4]. In the past 50 years, an estimated 17.7 million deaths might be related to smoking all over the world [5]. The effects of cigarette consumption and alcohol drinking on dementia among elderly people have been paid attention [6, 7]. The association of smoking and alcohol drinking with dementia risk has shown various results in past study. Some studies finding suggested that smoking was a risk factor of cognitive impairment for AD and VaD [8]. Another three researches hoped that nicotinic stimulation may have promise for improving cognitive [9]. In addition, several results have recently suggested that alcohol drinking in elderly people might impair cognitive function [10, 11], whereas others did not indicate that alcohol consumption would be harmful to cognition function, and it was not possible to define a specific beneficial level of alcohol drinking [12]. The study of dementia among elderly people has been taken in some large cities in China [13, 14]. China is a country with a large production and consumption of cigarette and alcohol. It is different from western countries in China that the cigarette and alcohol users are mainly in adult men, rather than in women. In past study, association of smoking and alcohol drinking with risk of dementia in both sexes was discussed together in China. The association was not specially analysed in men, so previous researches could not accurately reflect the effect of smoking and alcohol drinking on dementia. We examined the relationship of smoking, alcohol consumption with dementia, AD and VaD in a large cohort of elderly men.

MATERIALS AND METHODS

Study Population

Chongqing City is the largest city of the southwest region. Chongqing City has a population of 35 million people, and is the most population city in China. We randomly selected six neighbourhoods from three districts mentioned in Chongqing city. The following inclusion criteria were applied: (1) 60 years of age and older. (2) long-term residents of local communities. The exclusion criteria included (1) serious illness, severe hearing or visual impairment precluding a reliable assessment of cognitive function, (2) persistent impairment of consciousness, (3) previous long-lasting mental retardation, (4) no reliable information, (5) a history of severe head trauma or neurosurgery. The present study was approved by the Institutional Review Board of Daping Hospital and all men provided informed consent.

Baseline Screening

In this study, baseline screening was performed between January 1 and June 30, 2004. Formal questionnaire and neuropsychological tests for all men were completed at the community medical centers. For elderly men who were absent at these center, or who were not able to attend due to physical disabilities, our staff went to their home to perform the questionnaire and tests. Among 4057 examined men, 3728 men were eligible (response rate 92%), while 221 men were not available at the time of screening (n = 106) or declined to participate (n = 115). An additional 337 men were diagnosed with dementia and excluded. The remaining 3170 men without dementia were enrolled at baseline (Fig. ). The following data on formal questionnaire and neuropsychological tests were collected. These procedures were administered by experienced neurologists, psychiatrists and senior nurses. The agreement on data collection was excellent based on the κ values of 0.92 for baseline screening questionnaire and 0.91 for neuropsychological tests. The following data were collected at baseline, including age, weight, body mass index (BMI) and educational level and available medical records. Medical records were collected to clinical assessment. The assessment included presence of ischemic heart diseases, stroke, hypertension (systolic/diastolic blood pressure > 140/90 mmHg or being on antihypertensive treatment), diabetes mellitus (fasting blood glucose > 110 mg/dl or being on antidiabetic treatment), hypercholesterolemia (total cholesterol > 200 mg/dl). Measurements of blood pressure and electrocardiogram were performed on-site. In addition, fasting serum samples were collected at baseline and stored at -80°C for measurement of glucose, cholesterol and ApoE. Men with potential diseases that had not previously been diagnosed, were admitted to the Daping Hospital for further investigation and a diagnosis diseases state. The diagnosis of diseases, including ischemic heart diseases, stroke, hypertension, diabetes mellitus and hypercholesterolemia, were based on the International Classification of Diseases, 9th Revision (ICD-9).

Smoking and Alcohol Drinking

Tobacco smokers were classified as past smokers who had ceased smoking for at least 6 months, current smokers, or those who never smoked. Alcohol drinking status was classified as daily drinking, weekly drinking, monthly drinking, and occasional drinking. Non-smoking and drinking was neither smoking nor drinking, only smoking included past smoking and current smoking except drinking, only drinking included weekly drinking and monthly drinking except smoking. Co-smoking and drinking was defined as current smokers and daily drinking. In drinking men of our study, 86.3% men drank distilled spirit, 13.1% men drank beer, and only 0.6% men wine. In fact, 96.5% men drank distilled spirit and beer at the same time, so types of alcohol consumption were not analyzed in this study.

Diagnosis of Dementia

The diagnosis of dementia was described in our previous studies [15]. In brief, diagnosis of dementia was based on criteria modified from the DSM-IV [16]. The subjects with dementia were further subjected to brain CT or MRI. Diagnosis of AD dementia was made according to the criteria of National Institute of Neurological and Communicative Diseases and Stroke/AD and Related Disorders Association [17]. Diagnosis of vascular dementia (VaD) was based on the criteria of the National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherche et l’Enseignement en Neurosciences (NINDS-AIREN) [18]. The differentiation of AD from VaD is based on the NINDS-AIREN criteria and HIS (HIS≤4: AD, 4≤HIS≤7: mixed dementia (AD plus VaD), HIS ≥7: VaD [19]. The diagnosis of other dementias, including Parkinson's disease dementia, frontotemporal dementia, Lewy body dementia and Huntington’s disease, were based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) [16].

Follow-up

A total of 3170 men were followed up annually for 7 years from July 2004 to June 2011. These men were interviewed by questionnaire and neuropsychological tests at the community medical centers or our staff went to their home to perform the interview when needed. Cognitive status was re-assessed using the same neuropsychological tests as baseline screening. There was no difference in characteristics between dropped out and remained men in the study.

Statistical Analysis

Using univariate analyses, baseline variables between men with and without dementia were compared using the Pearson Chi square test, the Fisher exact test, the t test or the Mann-Whitney U test as deemed appropriate. We assessed the associations (hazard ratio) between smoking or drinking status and the risk of dementia development in the Cox proportional hazards models. The associations were firstly analyzed without adjustment for potential confounders. Then, the associations were further analyzed after adjustment for age BMI, education, ApoE and vascular risk factors. Finally, the statistical analyses were performed using SPSS 18.0 for Windows.

RESULTS

Baseline Characteristics in Men Who Did and Did not Develop Dementia

In the seven years course of the study, 91 (2.9%) men died, 48 (1.5%) declined to further participate, and 72 (2.3%) moved away from the area, leaving 2959 men who completed the follow-up (Fig. ). During follow-up, 357 cases of dementia were detected, of which 172 (48.2%) was AD, 156 (43.7%) were VaD and 29 (8.1%) were other dementias. For the men who completed the follow-up, the average age was 67.4±4.7 years. Compared with the men who did not develop dementia, those who did were significantly older, hypertension, diabetes mellitus, ischemic heart disease and stroke were more frequent in men with dementia, AD and VaD (p<0.01). Hypercholesterolemia was more prevalent in men with dementia, AD and VaD (p<0.05). ApoE was significantly more in men with dementia and AD (p<0.01), and VaD (p<0.05) (Table ).

Association of Smoking and Drinking with Dementia

Table showed the association of smoking and alcohol drinking with dementia incidence. Among the three groups of smoking, it was found that the men with current smoking had significantly higher incidence of AD and VaD than those with never smoking (p < 0.01). When the four groups of drinking was analysed, the men with weekly drinking had significantly higher incidence of dementia and VaD than those with occasional drinking (p < 0.05). The association was even stronger when daily drinking was considered, showing a similar trend in dementia, AD and VaD (p < 0.01). While the men with Co-smoking and drinking had significantly higher incidence of dementia, AD and VaD than those with non-smoking and drinking (p < 0.01). Other dementias in our dementia classification included Parkinson's disease dementia 10 cases, frontotemporal dementia 9 cases, Lewy body dementia 7 cases and Huntington’s disease 3 cases. The number of other dementia cases was smaller, so the correlation of smoking and alcohol drinking with other dementias was not further researched.

Dementia Incidence by Age and Smoking and Drinking Status

Fig. ( showed dementia incidence over 7 years of follow-up by age and smoking, drinking status. These men were divided into three groups according to age. As follows: 60- to 69-year-old group, the 70- to 79-year-old group and the ≧ 80-year-old group. Interestingly, in each age-group, the incidence of Alzheimer’s disease per 100 person-years was significantly higher in co-smoking, drinking status than in current smoking and daily drinking (p < 0.01). In each age-group, the incidence of vascular dementia per 100 person-years was significantly higher in co-smoking, drinking status than in current smoking and daily drinking (p < 0.01).
Fig. (2)

Incidence of dementia per 100 person-years at 7 years end of follow-up by age and smoking, drinking status in men. These men were divided into three groups according to age. A. each age-group, the incidence of Alzheimer’s disease per 100 person-years was significantly higher in co-smoking, drinking status than in current smoking and daily drinking (p < 0.01). B. In each age-group, the incidence of vascular dementia per 100 person-years was significantly higher in co-smoking, drinking status than in current smoking and daily drinking (p < 0.01).

Relationship Between Smoking, Alcohol Drinking and Dementia in Cox Proportional Hazard Regression Model

The relationship between smoking or drinking status and incidence of dementia was shown in (Table ). After adjusting for age, BMI, education, ApoE, vascular risk factors, it was noteworthy that current smoking was associated with a significantly higher risk of AD and VaD than never smoking, and daily drinking was associated with a significantly higher risk of AD and VaD than occasional drinking. In addition, co-smoking and drinking were related to with a significantly higher risk of AD and VaD than non-smoking and drinking. Moreover, co-smoking and drinking had higher risk of AD and VaD compared with current smoking and daily drinking.

DISCUSSION

Our study firstly showed that current smoking was associated with a 2.1-fold greater risk of AD and a 3.3-fold greater risk of VaD, and daily drinking was associated with a 2.3-fold greater risk of AD and a 3.4-fold greater risk of VaD, and co-smoking and drinking was also associated with a 3-fold greater risk of AD and a 3.9-fold greater risk of VaD in Chinese elderly men. Moreover, co-smoking and drinking had higher risk of AD and VaD compared with current smoking and daily drinking. Our study indicated the incidence of VaD in China is higher than that in other counties [20]. It could be related to high development of stroke and vascular risk factors in China. In 2011, a study summarized the potentially modifiable risk factors for AD: smoking, diabetes, midlife hypertension, and so on [21]. Together, up to half of AD cases worldwide and in the USA are potentially attributable to these factors. A 10-25% reduction in all seven risk factors could potentially prevent as many as 1·1-3·0 million AD cases worldwide and 184,000-492,000 cases in the USA. Some studies revealed the association of smoking and alcohol drinking status with incidence of dementia [22, 23]. Park et al. [24] evaluated cognitive function impairment, smoking and drinking status in 3,174 inhabitants aged 60–64 years in Korea, with a follow-up assessment of cognitive function 7 years later. Current smokers showed a higher risk for developing cognitive function impairment than did never smokers. Nevertheless, for AD, the results examined the association between smoking, alcohol drinking and AD, and suggested that heavy drinking and smoking and ApoE can lower the age of onset for AD in an additive fashion [25]. García et al. [26] performed a case-control study. Risk of AD was unaffected by tobacco smoking, alcohol drinkers also showed a lower risk of AD than never consumers. Furthermore, excessive smoking and alcohol consumption has a great effect on VaD in our study. For VaD, there is substantial evidence from observational studies that conventional risk factors such as smoking, hypertension, diabetes and dyslipidemia play a role in the development of vascular cognitive impairment [27]. Smoking was associated with an increased rate of progression of vascular brain injury and decline in executive function a decade later [28]. Panza et al. [29] reported that light to moderate alcohol drinking might be associated with a reduced risk of unspecified incident dementia and AD, while for VaD, the current result is only suggestive of a protective effect. It has been argued that joint effects of alcohol and tobacco use on ADs [30, 31]. In recent study, interaction between tobacco and alcohol consumption with AD was investigated. Unadjusted logistic regression model showed statistical significance for the interaction term between tobacco and alcohol, and this interaction term was also statistically significant in the model including our potentially confounding variables [26]. We assessed the interactions between tobacco and alcohol in large prospective studies, and found the joint effects of alcohol and tobacco use on AD and VaD. There have been different results about the type of alcohol and risk of dementia. In the previous study, we suggested that a significantly lower risk of dementia existed for light-to-moderate drinkers of wine. A light-to-moderate intake of beer was associated with a significantly higher risk of dementia. Copenhagen study revealed that monthly and weekly intake of wine was significantly associated with a lower risk of dementia [32]. A monthly intake of beer was associated with increased risk of dementia. However, Rotterdam Study did not find the relationship between alcohol and dementia depended on the type of alcoholic beverage [33]. Gender, drinking patterns, interactions with other lifestyle-related and genetic factors genotyping may be sources of great variability. Previous studies on smoking, drinking and dementia stratified by gender showed contradictory results. A study suggested that frequent alcohol drinking increased the risk of developing cognitive impairment among male subjects (P =0.044) [24]. Another report from a Japanese rural community revealed that smoking was associated with an increased risk of disabling dementia. A twofold excess risk was found for smoking duration of ≥45 years. For men, we also found that excessive smoking and drinking were associated with increased risk of dementia [34]. Smoking and alcohol drinking were found to be significantly related to the development of dementia [35, 36]. However, the mechanism by which smoking and alcohol drinking contributes to dementia is unclear. Evidence from neuropathological and clinical studies suggested considerable overlap in risk factors of AD and VaD, and two diseases shared common pathogenic mechanisms. Zhu and others [37] demonstrated that oxidative stress is the earliest pathological changes of the brain in AD patients. Ho et al. [8] investigated the cigarette smoke-induced pathological changes and significantly increased levels of oxidative stress in AD rats. Cigarette impacted amyloid precursor protein (APP) processing by increasing the production of APPβ and accumulation of β–amyloid peptide. Ritchie et al. [38] suggested the hypothesis that a genetic score for alcohol processing capacity moderates the association between alcohol consumption and lifetime change in cognitive ability. A significant gene × alcohol consumption interaction on lifetime cognitive change was found (p = 0.007). The effect of alcohol drinking on cognitive change may thus depend on genetic differences in the ability to metabolize alcohol. The associated of apoE with risk of AD have been defined through in the study, APOE plays a critical role in transporting cholesterol in AD [39]. The effects of apoE isoforms on AD have been confirmed in humans, animal models and cellular studies. This evidence revealed the ε4 allele of the APOE gene is a stronger genetic risk factor for AD than the more common ε3 allele, whereas the presence of the ε2 allele is protective [40, 41]. The ε4 allele of the APOE gene not only dose dependently increases the risk for AD but also lowers the age of onset. ApoE4 contributes to the pathogenesis of AD by both loss-of-function in neuroprotection and gain-of-function in neurotoxicity compared to apoE3 [40, 42]. Whether apoE4 confers a risk for the development of VaD has been intensive investigation with conflicting conclusions. The results revealed a positive association between harboring the APOE4 allele and increased risk for VaD [43-45]. However, another studies found that APOE4 allele does not confer risk for VaD [46, 47]. In recent reports, alleles for alcohol dehydrogenase (ADH) and aldehyde dehydrogenases (ALDH) had been implicated in the risk of AD. Lewis et al. [48] used a set of four SNPs in ADH three genes (ADH1A, ADH1B, and ADH7) to examine the effect of maternal consumption of alcohol on offspring cognition. The total number of rare alleles on this SNP set interacted significantly with alcohol drinking. Moreover, ALDH not only transform aldehydes to acids but also act as antioxidant enzymes. This study found that the mitochondrial ALDH activity was significantly increased in the putamen of patients with AD compared to controls [49]. In addition, a Mendelian randomization study carried out in southern Chinese men, in which alcohol drinking is low to moderate and is influenced by genotype, offers an alternative and superior approach for clarifying the causal effect of moderate alcohol drinking on cognitive function [50]. ALHD2 genotype was strongly associated with alcohol consumption. Lahiri DK et al. [51] proposed the LEARn (Latent Early-life Associated Regulation) model for AD. LEARn-AD might be a “two-hit” disorder, wherein the first hit might occur due to environmental stress within the regulatory sequences of AD-associated genes. This hit might come in early childhood. The second hit could consist of further stress, such as poor mid-life diet, or changes in expression of genes that occur later in life independent of any pathogenesis. Further, the LEARn model operates through the regulatory region of the gene, specifically through changes in methylation and oxidation within the promoter of specific genes [52]. The LEARn model combines genetic and environmental risk factors in an epigenetic pathway to explain the etiology of the most common forms of neurobiological disorders. Additionally, this study suggested that the LEARn model might explain the etiology of AD and other neuropsychiatric disorders [53]. The model provides us with a novel direction for identifying potentially harmful agents that may induce neurodegeneration and provides hope that we may be able to prevent age-related neurodegenerative disease by “detoxifying” our environment [54]. There were several limitations in the present study. First, the association between different types of alcohol beverage and dementia was not observed in this study. Some results pointed to a protective effect of alcohol drinking, mostly associated to wine consumption [55, 56]. Second, vascular contributions to cognitive impairment and dementia are important. Carotid artery stenosis, carotid intimal-medial thick and bilateral present carotid plaques were not assessed in this study, which might be associated with AD and VaD [57]. Third, another limitation is that measurements of confounding factors, including smoking and alcohol consumption status, were based on self-report. In conclusion, the present study revealed that heavy smoking and drinking were related to the incidence of both AD and VaD, and a higher risk of dementia in men. Thus, these findings might suggest that to control smoking and drinking could be of importance for decreasing dementia incidence.

Sponsor’s Role

All sponsors have funded the underlying research scope of all respective authors where related aims are applicable to this study. However, no specific sponsor was explicitly involved in the design, methods, subject recruitment, data collection, analysis, and/or preparation of this particular manuscript.

Author Contributions

Shiming Zhou designed the study concept, Rui Zhou, Tingting Zhong and Rui Li aquired the subjects and clinical data. Shiming Zhou analyzed the data, and with Huadong Zhou, Rui Li and Rui Zhou performed further data analyses and interpretation. Shiming Zhou and Huadong Zhou drafted the manuscript and all authors revised and finally approved the initial manuscript and its revision.
Table 1

Baseline characteristics of men who developed dementia and who did not.

Did not Develop Dementia All Developed Dementia Developed Dementia
AD VaD Other Dementia
n =2602 n = 357 n = 172 n = 156 n = 29
Physical characteristics
Age (years), ±SD67.1±4.769.6±4.6* 69.3±4.7* 69.8±4.6* 70.9±4.5*
Weight (Kg), ±SD64.7±10.564.4±10.364.2±10.264.5±10.164.8±9.9
BMI (kg/m2), ±SD22.1±3.822.4± 3.622.3±3.622.4±3.622.5±3.5
Education (years), ±SD11.2±5.110.9±4.910.6±4.811.3±5.010.9±4.8
ApoE ε4 n (%)343(13.2)65 (18.2) * 32(18.6) * * 30(19.2) * * 3 (10.3)
Vascular risk factors
Hypertension, n (%)759(29.2)128 (35.9) * 63(36.6) * * 61(39.1) * 4(13.8)
Diabetes mellitus, n (%)629(24.2)109 (30.5) * 54(31.4) * * 52(33.3) * 3 (10.3)
Hypercholesterolemia, n (%)617(23.7)105 (29.4) * * 53(30.8) * * 48(30.8) * * 11(37.9)
Ischemic heart disease, n (%)380(14.6)72(20.2) * 35(20.3) * * 32(20.5) * * 5(17.2)
Stroke, n (%)487(18.7)88 (24.6) * 43(25.0) * * 43(27.6) * 2(6.9)

BMI: body mass index, AD: Alzheimer disease, VaD: vascular dementia

Two sided p values for χ2 test and t test, * p<0.01; * * p<0.05 vs did not develop dementia

Table 2

Dementia incidence in smoking, alcohol drinking status for men.

Total Did not Develop Dementia All Developed Dementia Developed Dementia
AD VaD Other Dementia
n =2959 n =2602 n =357 n =172 n =156 n =29
Smoking status
Never smoking n (%)829(28.0)734(28.2)95(26.6)44(25.6)41 (26.3)10(34.5)
Past smoking n (%)879(29.7)778(29.9)101(28.3)46(26.7)43(27.6)12(41.4)
Current smoking n (%)1251(42.3)1090 (41.9)161(45.1)* 82(47.7)* 72(46.2)* 7(24.1)
Drinking status
Occasional drinking n (%)765(25.8)674 (42.5)91(25.5)38(22.1)42 (26.9)11(38.0)
Monthly drinking n (%)491(16.6)440 (16.9)51(14.3)25(14.5)21(13.5)5(17.2)
Weekly drinking n (%)402(13.6)361(13.9)41(11.5)* * 18(10.5)16(10.3)* * 7(24.1)
Daily drinking n (%)1301(44.0)1127(43.3)174 (48.7)* 91(52.9)* 77(49.4)* 6 (20.7)
Co-smoking and drinking status1134(38.3)1325(50.9)203 (56.9)* 105 (61.0)* 89 (57.1)* 9 (31.0)

Co-smoking and drinking: co-existence of smoking and drinking

Two sided p values for χ2 test

* p<0.01 vs never smoking or occasional drinking or Non- smoking and drinking

* * p<0.05 vs never smoking or occasional drinking or Non- smoking and drinking

Table 3

Relationship between smoking, alcohol drinking and dementia risk in Cox proportional hazard regression model in men.

Alzheimer’s Disease Vascular Dementia Other Dementia
Crude HR for AD (95% CI) Adjusted HR for AD (95% CI) * Crude HR for VaD (95% CI) Adjusted HR for VaD (95% CI) * Crude HR for Other Dementia (95% CI) Adjusted HR for Other Dementia (95% CI) *
Smoking status
Never smoking111111
Past smoking1.21(0.87-2.28)1.20(0.89-2.31)1.27(0.92-2.18)1.25(0.93-2.21)1.14(0.72-1.93)1.15(0.76-1.96)
Current smoking2.15(1.21-4.06)2.14(1.20-4.46)3.25(1.29-4.27)3.28(1.14-4.52)1.21(0.79-1.36)1.18(0.72-1.39)
Drinking status
Occasional drinking111111
Monthly drinking1.06(0.76-1.32)1.03(0.83-1.35)1.12(0.67-1.29)1.18(0.86-1.24)1.13(0.58-1.36)1.01(0.69-1.28)
Weekly drinking1.28(0.75-1.31)1.31(0.69-1.43)1.37(0.87-1.29)1.35(0.82-1.25)1.07(0.70-1.29)1.09(0.76-1.34)
Daily drinking2.29(1.45-3.92)2.25(1.43-3.97)3.34(1.29-4.28)3.42(1.18-4.51)1.08(0.81-1.36)1.06(0.82-1.39)
Co-smoking and drinking status
Non-smoking and drinking111111
Only smoking1.01(0.82-1.12)1.01(0.86-1.13)1.02(0.76-1.06)1.06(0.77-1.08)1.01(0.71-1.02)1.01(0.74-1.03)
Only drinking1.03(0.96-1.14)1.03(0.97-1.14)1.03(0.82-1.07)1.05(0.85-1.09)1.01(0.72-1.03)1.01(0.74-1.04)
Co-smoking and drinking3.02(1.61-4.16)3.03(1.65-4.19)3.94(1.63-4.68)3.96(1.64-4.71)1.12(1.13-1.27)1.12(1.14-1.28)

Co-smoking and drinking: co-existence of smoking and drinking

HR: hazard ratio, CI: confidence interval

* adjusted for age, BMI, education, ApoE, vascular risk factors

TABLE
Elements of Financial/Personal Conflicts Huadong Zhou Shiming Zhou Rui Zhou Tingting Zhong Rui Li Jun Tan
Yes No Yes No Yes No Yes No
Employment or AffiliationNoNoNoNo
Grants/FundsNoNoNoNo
HonorariaNoNoNoNo
Speaker ForumNoNoNoNo
ConsultantNoNoNoNo
StocksNoNoNoNo
RoyaltiesNoNoNoNo
Expert TestimonyNoNoNoNo
Board MemberNoNoNoNo
PatentsNoNoNoNo
Personal RelationshipNoNoNoNo
  56 in total

Review 1.  Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes.

Authors:  Francesco Panza; Cristiano Capurso; Alessia D'Introno; Anna M Colacicco; Vincenza Frisardi; Maria Lorusso; Andrea Santamato; Davide Seripa; Alberto Pilotto; Emanuele Scafato; Gianluigi Vendemiale; Antonio Capurso; Vincenzo Solfrizzi
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

2.  Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.

Authors:  Giuseppe Orsitto; Davide Seripa; Francesco Panza; Marilisa Franceschi; Leandro Cascavilla; Giuliana Placentino; Maria Giovanna Matera; Francesco Paris; Cristiano Capurso; Vincenzo Solfrizzi; Bruno Dallapiccola; Alberto Pilotto
Journal:  Dement Geriatr Cogn Disord       Date:  2007-03-19       Impact factor: 2.959

Review 3.  Vascular oxidative stress in Alzheimer disease.

Authors:  Xiongwei Zhu; Mark A Smith; Kazuhiro Honda; Gjumrakch Aliev; Paula I Moreira; Akihiko Nunomura; Gemma Casadesus; Peggy L R Harris; Sandra L Siedlak; George Perry
Journal:  J Neurol Sci       Date:  2007-03-06       Impact factor: 3.181

4.  Alcohol and cause-specific mortality in Russia: a retrospective case-control study of 48,557 adult deaths.

Authors:  David Zaridze; Paul Brennan; Jillian Boreham; Alex Boroda; Rostislav Karpov; Alexander Lazarev; Irina Konobeevskaya; Vladimir Igitov; Tatiana Terechova; Paolo Boffetta; Richard Peto
Journal:  Lancet       Date:  2009-06-27       Impact factor: 79.321

5.  The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases.

Authors:  D K Lahiri; B Maloney; N H Zawia
Journal:  Mol Psychiatry       Date:  2009-11       Impact factor: 15.992

6.  The "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

7.  Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) in the putamen of individuals with Alzheimer's disease: a human postmortem study.

Authors:  Tanja Maria Michel; Wieland Gsell; Ludwig Käsbauer; Thomas Tatschner; Abigail Jane Sheldrick; Irene Neuner; Frank Schneider; Edna Grünblatt; Peter Riederer
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Cigarette smoking and risk of disabling dementia in a Japanese rural community: a nested case-control study.

Authors:  Ai Ikeda; Kazumasa Yamagishi; Takeshi Tanigawa; Renzhe Cui; Masayuki Yao; Hiroyuki Noda; Mitsumasa Umesawa; Choylye Chei; Kimiko Yokota; Yumi Shiina; Mitiko Harada; Keiko Murata; Takashi Asada; Takashi Shimamoto; Hiroyasu Iso
Journal:  Cerebrovasc Dis       Date:  2008-02-27       Impact factor: 2.762

Review 9.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

10.  Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.

Authors:  Neal D Freedman; Michael F Leitzmann; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet
Journal:  Lancet Oncol       Date:  2008-06-13       Impact factor: 41.316

View more
  23 in total

1.  PCSK9 is Increased in Cerebrospinal Fluid of Individuals With Alcohol Use Disorder.

Authors:  Ji Soo Lee; Daniel Rosoff; Audrey Luo; Martha Longley; Monte Phillips; Katrin Charlet; Christine Muench; Jeesun Jung; Falk W Lohoff
Journal:  Alcohol Clin Exp Res       Date:  2019-05-03       Impact factor: 3.455

2.  The combined association of alcohol consumption with dementia risk is likely biased due to lacking account of death cases.

Authors:  Nadine Binder; Lisa Manderscheid; Martin Schumacher
Journal:  Eur J Epidemiol       Date:  2017-05-15       Impact factor: 8.082

3.  Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies.

Authors:  Wei Xu; Huifu Wang; Yu Wan; Chenchen Tan; Jieqiong Li; Lan Tan; Jin-Tai Yu
Journal:  Eur J Epidemiol       Date:  2017-01-17       Impact factor: 8.082

4.  Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis.

Authors:  Simon Zhornitsky; Shefali Chaudhary; Thang M Le; Yu Chen; Sheng Zhang; Stéphane Potvin; Herta H Chao; Christopher H van Dyck; Chiang-Shan R Li
Journal:  Psychiatry Res Neuroimaging       Date:  2021-08-29       Impact factor: 2.376

Review 5.  Progress towards the 2030 sustainable development goals: direct and indirect impacts on neurological disorders.

Authors:  Farrah J Mateen
Journal:  J Neurol       Date:  2022-05-18       Impact factor: 6.682

6.  Association of healthy lifestyle with cognitive function among Chinese older adults.

Authors:  Zheng Xie; Tao Huang; Zhebin Wang; Yuanjie Pang; Jie Liu; Jing Wang
Journal:  Eur J Clin Nutr       Date:  2020-10-28       Impact factor: 4.016

7.  Marital loss and risk of dementia: Do race and gender matter?

Authors:  Zhenmei Zhang; Hui Liu; Seung-Won Emily Choi
Journal:  Soc Sci Med       Date:  2021-03-02       Impact factor: 4.634

8.  Concurrent smoking and alcohol consumers had higher triglyceride glucose indices than either only smokers or alcohol consumers: a cross-sectional study in Korea.

Authors:  Wonhee Baek; Ji-Won Lee; Hye Sun Lee; Donghee Han; Su-Yeon Choi; Eun Ju Chun; Hae-Won Han; Sung Hak Park; Jidong Sung; Hae Ok Jung; Hyangkyu Lee; Hyuk-Jae Chang
Journal:  Lipids Health Dis       Date:  2021-05-11       Impact factor: 3.876

9.  Relation of cigarette smoking and alcohol drinking in midlife with risk of cognitive impairment in late life: the Singapore Chinese Health Study.

Authors:  Jing Wu; Wenhong Dong; Xiong-Fei Pan; Lei Feng; Jian-Min Yuan; An Pan; Woon-Puay Koh
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

Review 10.  Effect of alcohol on the central nervous system to develop neurological disorder: pathophysiological and lifestyle modulation can be potential therapeutic options for alcohol-induced neurotoxication.

Authors:  Zinia Pervin; Julia M Stephen
Journal:  AIMS Neurosci       Date:  2021-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.